1198-37-4 | 2,4-Dimethylquinoline

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$30.00	$21.00
5g	98%	in stock	$85.00	$60.00
10g	98%	in stock	$135.00	$95.00

Description

• Catalog Number: AA33062
• Chemical Name: 2,4-Dimethylquinoline
• CAS Number: 1198-37-4
• Molecular Formula: C11H11N
• Molecular Weight: 157.2117
• MDL Number: MFCD00006760
• SMILES: Cc1cc(C)c2c(n1)cccc2
• NSC Number: 62132

Computed Properties

• Complexity: 155
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 1
• XLogP3: 3

Upstream Synthesis Route

2,4-Dimethylquinoline is a versatile compound that finds applications in various chemical synthesis processes. Its unique structure makes it a valuable building block in the production of pharmaceuticals, agrochemicals, and specialty chemicals. In organic synthesis, 2,4-Dimethylquinoline serves as a key intermediate in the preparation of complex molecules due to its ability to undergo diverse chemical transformations. It is commonly used as a ligand in transition metal catalysis, enabling selective bond formations and facilitating intricate reaction mechanisms. Additionally, 2,4-Dimethylquinoline can act as a stabilizer in polymerization reactions, enhancing the efficiency and quality of the final polymer products. Its role as a versatile reagent in chemical transformations makes it an indispensable tool for researchers and professionals in the field of chemistry.

Literature

• Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques.

  European journal of medicinal chemistry 20090501

• Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides.

  Journal of medicinal chemistry 20060615

• Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.

  Journal of medicinal chemistry 20050602

• Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.

  Journal of medicinal chemistry 20050127